Epigenetic Therapy in Lung Cancer – Role of microRNAs

Lung cancer is the leading cause of cancer deaths worldwide. microRNAs (miRNAs) are a class of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological processes such as cellular differentiation, proliferation, apoptosis, and stem cell main...

Descripción completa

Detalles Bibliográficos
Autor principal: Rothschild, Sacha I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685817/
https://www.ncbi.nlm.nih.gov/pubmed/23802096
http://dx.doi.org/10.3389/fonc.2013.00158
_version_ 1782273744227532800
author Rothschild, Sacha I.
author_facet Rothschild, Sacha I.
author_sort Rothschild, Sacha I.
collection PubMed
description Lung cancer is the leading cause of cancer deaths worldwide. microRNAs (miRNAs) are a class of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological processes such as cellular differentiation, proliferation, apoptosis, and stem cell maintenance. Some miRNAs have been categorized as “oncomiRs” as opposed to “tumor suppressor miRs.” This review focuses on the role of miRNAs in the lung cancer carcinogenesis and their potential as diagnostic, prognostic, or predictive markers.
format Online
Article
Text
id pubmed-3685817
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-36858172013-06-25 Epigenetic Therapy in Lung Cancer – Role of microRNAs Rothschild, Sacha I. Front Oncol Oncology Lung cancer is the leading cause of cancer deaths worldwide. microRNAs (miRNAs) are a class of small non-coding RNA species that have been implicated in the control of many fundamental cellular and physiological processes such as cellular differentiation, proliferation, apoptosis, and stem cell maintenance. Some miRNAs have been categorized as “oncomiRs” as opposed to “tumor suppressor miRs.” This review focuses on the role of miRNAs in the lung cancer carcinogenesis and their potential as diagnostic, prognostic, or predictive markers. Frontiers Media S.A. 2013-06-19 /pmc/articles/PMC3685817/ /pubmed/23802096 http://dx.doi.org/10.3389/fonc.2013.00158 Text en Copyright © 2013 Rothschild. http://creativecommons.org/licenses/by/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
spellingShingle Oncology
Rothschild, Sacha I.
Epigenetic Therapy in Lung Cancer – Role of microRNAs
title Epigenetic Therapy in Lung Cancer – Role of microRNAs
title_full Epigenetic Therapy in Lung Cancer – Role of microRNAs
title_fullStr Epigenetic Therapy in Lung Cancer – Role of microRNAs
title_full_unstemmed Epigenetic Therapy in Lung Cancer – Role of microRNAs
title_short Epigenetic Therapy in Lung Cancer – Role of microRNAs
title_sort epigenetic therapy in lung cancer – role of micrornas
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685817/
https://www.ncbi.nlm.nih.gov/pubmed/23802096
http://dx.doi.org/10.3389/fonc.2013.00158
work_keys_str_mv AT rothschildsachai epigenetictherapyinlungcancerroleofmicrornas

Ejemplares similares